Skoltech-CNBR1
The Study on the еffectiveness of the Integration of a Device Based on a Neural Interface and Neurostimulation of the Spinal Cord in the Rehabilitation of Patients With Upper Limb Movement Impairments Due to Neurological Disorders.
Постоянная ссылка: https://clinomir.ru/trials/nct/NCT05115149/
Источник: ClinicalTrials.gov (U.S. National Library of Medicine). Что откуда
Простыми словами
Словарь терминов- В исследовании участвуют здоровые добровольцы.
- Статус исследования в реестре не указан — уточняйте в центре.
- Возраст участников: 18–60 лет. Остальные условия — в блоке «Кто может участвовать».
- По плану участвуют 60 чел. во всех странах исследования.
- Центров в реестре: 6 в 4 городах. Список — ниже на странице.
- Плановая дата окончания (12.2023) уже прошла.
Пересказ собран автоматически из данных реестра, без оценки пользы и рисков. Подробно о рисках и пользе рассказывает врач центра перед подписанием согласия.
Кто может участвовать
Полный текст критериев (на английском, как в ClinicalTrials.gov) · включение: 13 · невключение: 25
Критерии включения
- Criteria for inclusion in the study of patients:
- Signed written informed consent.
- Men or women aged 18 to 60 years after a first occurred acute cerebrovascular accident or in the recovery period after injury of the cervical and upper thoracic spinal cord.
- Early or late rehabilitation period of acute cerebrovascular accident by the type of ischemic stroke or the consequences of SCI in the late recovery period
- Diagnosis of "acute ischemic cerebrovascular accident", or a condition after spinal cord injury at the C3-C7 level, moderate or high severity ASIA A and ASIA B, according to the discharge summary, MRI or CT.
- For groups of patients with stroke: the degree of severity of paresis of the upper limb from 3 points to 0 (according to the 6-point MRC muscle strength scale https://cpd-program.ru/methods/mrc.htm)
- The patient's ability and willingness to comply with the requirements of this protocol.
- Expressed patient motivation for rehabilitation.
- Inclusion criteria for healthy volunteers:
- Signed written informed consent.
- Men or women between the ages of 18 and 40
- Absence of somatic and psychiatric diseases (according to the reports of the subject and according to the examination of a medical specialist before the start of the study)
- Ability and willingness to comply with the requirements of this protocol.
Критерии невключения
- Severe cognitive impairment (<10 points on the Montreal Cognitive Assessment Scale).
- The score on the Hamilton scale is above 18 points.
- The rating on the Rankin scale is higher than 4 points.
- Concomitant diseases that cause a decrease in muscle strength or an increase in muscle tone in the upper limbs (for example, cerebral palsy, brain damage as a result of trauma) or rigidity (for example, Parkinson's disease, contracture).
- Late stages of arthritis or significant limitation of range of motion.
- The absence of a part of the upper limb due to amputation caused by various reasons.
- Any medical condition, including mental illness or epilepsy, that may affect the interpretation of the test results, the conduct of the test, or the safety of the patient.
- Alcohol abuse, medical marijuana use, or light drug use in the previous 12 months.
- Use of experimental drugs or medical devices within the previous 30 days prior to Visit 1.
- Inability to comply with research procedures, according to the researcher.
- The severity of the patient's condition according to the data of the neurological or somatic status, which does not allow full rehabilitation
- Visual acuity less than 0.2 in the weakest eye according to the table of visual acuity of Sivtsev.
- Unstable angina and / or heart attack during the previous month
- History of stroke (for patients with spinal cord injury) or recurrent stroke (for patients with acute cerebrovascular accident).
- Uncontrolled arterial hypertension.
- Ataxia.
- Pacemaker and / or other implanted electronic devices.
- Taking muscle relaxants.
- Peripheral neuropathy.
- Concomitant diseases in the stage of exacerbation or decompensation, requiring active therapy.
- The presence of allergic reactions and / or other skin lesions at the place of application of the heart rate electrodes at the time of the study.
- Acute urinary tract infections.
- Acute thrombophlebitis.
- All forms of epilepsy.
- Benign and malignant neoplasms.
Источник: ClinicalTrials.gov, NCT05115149 · запись обновлена в реестре 10 ноября 2021.
Дизайн и результаты
Что измеряют — первичные конечные точки (4), вторичных — 16
- Change from Baseline Fugl-Meyer scale for the upper limb after the rehabilitation procedures — 2 weeks
- Change from Baseline Fugl-Meyer scale for the upper limb in four weeks after the rehabilitation procedures — up to 6 weeks
- Change from Baseline Action Research Arm Test after the rehabilitation procedures — 2 weeks
- Change from Baseline Action Research Arm Test in four weeks after the rehabilitation procedures — up to 6 weeks
Цель исследования
The aim of the study is to investigate the effectiveness of a new rehabilitation technology for paralysis that occurs after stroke or spinal cord injury. The research will jointly use a prototype neurorehabilitation orthosis, in which a robotic device moves a paralyzed arm at the command of a non-invasive brain-computer interface to perform a game life-like task augmented using a virtual-reality display, as well as an electrical stimulation device that activates the spinal cord and/or muscles of the paralyzed arm.
Investigators expect that a portion of the patients participating in the study will have an improvement in arm mobility by the end of the study.
Participants who express their special written consent will have venous blood tests conducted three times for subsequent analysis of lipid biomarkers, in order to further evaluate the effectiveness of rehabilitation methods based on biochemical analysis.
Где проходит
6 центров в 4 городахОткуда эта информация
-
ClinicalTrials.gov (U.S. National Library of Medicine) · NCT05115149 Официальный реестр (США) · загружено 9 ноября 2026Номер протокола, название, цель, сроки, число участников, спонсор, центры
Сведения сведены и нормализованы порталом «Клиномир»: названия компаний и центров приведены к одному написанию. Нашли ошибку? Напишите нам — исправим.